Gosuè Scognamiglio

12PUBLICATIONS
75CO-AUTHORS
Gene and molecular therapyPredictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Solid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 02, 2026
RETRACTED: Zito Marino et al. AXL and MET Tyrosine Kinase Receptors Co-Expression as a Potential Therapeutic Target in Malignant Pleural Mesothelioma. J. Pers. Med. 2022, 12, 1993.

|Mar 29, 2023
Oligo-Metastatic Cancers: Putative Biomarkers, Emerging Challenges and New Perspectives.

Alessandro Ottaiano, Mariachiara Santorsola, Luisa Circelli

|Dec 23, 2022
RETRACTED: AXL and MET Tyrosine Kinase Receptors Co-Expression as a Potential Therapeutic Target in Malignant Pleural Mesothelioma.

Federica Zito Marino, Carminia Maria Della Corte, Vincenza Ciaramella

|Dec 22, 2022
Combination of Spirulina platensis, Ganoderma lucidum and Moringa oleifera Improves Cardiac Functions and Reduces Pro-Inflammatory Biomarkers in Preclinical Models of Short-Term Doxorubicin-Mediated Cardiotoxicity: New Frontiers in Cardioncology?

Vincenzo Quagliariello, Manuela Giovanna Basilicata, Giacomo Pepe

|Nov 11, 2022
CXCR4-CXCL12-CXCR7 and PD-1/PD-L1 in Pancreatic Cancer: CXCL12 Predicts Survival of Radically Resected Patients.

Crescenzo D'Alterio, Alessandro Giardino, Giosuè Scognamiglio

|Sep 23, 2022
Analysis of A Disintegrin and Metalloprotease 17 (ADAM17) Expression as a Prognostic Marker in Ovarian Cancer Patients Undergoing First-Line Treatment Plus Bevacizumab.

Marina Fabbi, Delfina Costa, Daniela Russo

Pageof 2

Frequent Collaborators

5 joint publications

Annabella Di Mauro

4 joint publications

Fabiana Tatangelo

2 joint publications

Alessandro Ottaiano

2 joint publications

Paolo Chiodini